Online citations, reference lists, and bibliographies.

Double-blind, Right/left Comparison Of Calcipotriol Ointment And Betamethasone Ointment In The Treatment Of Prurigo Nodularis.

S Wong, Chee Leok Goh
Published 2000 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share



This paper is referenced by
Excimer laser versus clobetasol propionate 0 . 05 % ointment in prurigo form of atopic dermatitis : a randomized controlled trial , a pilot Submitted
Elian E. A. Brenninkmeijer (2009)
Topica l ca lcipotriol in derma tology
Atif Shahzad (2006)
10.3109/09546630903386606
An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis
Rosita Saraceno (2010)
Zastosowanie witaminy D, jej metabolitów i analogów w lecznictwie dermatologicznym Vitamin D, its metabolites and analogues in dermatological treatment
Anna sysa-Jędrzejowska (2009)
10.2310/7750.2013.13109
Off-Label Uses of Topical Vitamin D in Dermatology: A Systematic Review
Heidi Wat (2014)
10.1111/j.1365-2133.2010.09858.x
Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot.
Elian E. A. Brenninkmeijer (2010)
10.1016/j.sder.2011.04.008
Topical therapies for pruritus.
Sarina B. Elmariah (2011)
10.1111/j.1440-0960.2005.00187.x
Prurigo nodularis: a review.
Michael R. Lee (2005)
10.1016/j.det.2018.02.003
Prurigo Nodularis and Its Management.
Claudia Zeidler (2018)
Prurigo nodularis
Sibylle Eigelshoven (2010)
Prurigo nodularis: a benign dermatosis derived from a persistent pruritus.
Darshan C Vaidya (2008)
10.1001/archdermatol.2011.2918
Treatment of refractory prurigo nodularis with lenalidomide.
Holly E Kanavy (2012)
10.1177/120347540200600507
Nonpsoriatic Uses of Calcipotriol
Aditya K Gupta (2002)
10.1002/9781119142812.ch17
Atopic Dermatitis and Related Disorders: Special Types of Presentation
Nawaf Almutairi (2019)
10.1515/chem-2020-0042
Keratin 17 is induced in prurigo nodularis lesions
Lili Yang (2020)
10.3109/09546634.2013.814759
Prurigo nodularis: an update on etiopathogenesis and therapy
Anna Chiara Fostini (2013)
10.2340/00015555-2774
Chronic Prurigo of Nodular Type: A Review.
Claudia Zeidler (2018)
10.1016/j.jaad.2018.09.020
A systematic review of evidence‐based treatments for prurigo nodularis
Azam A. Qureshi (2019)
10.2147/CCID.S188070
Treatment-resistant prurigo nodularis: challenges and solutions
Eric H. Kowalski (2019)
10.1684/ejd.2017.3164
The use of biodegradable microneedle patches to increase penetration of topical steroid for prurigo nodularis
J U Shin (2018)
Vitamin D and its Analogs: Dermatologic uses
Dalia Shaaban (2011)
10.1016/j.annder.2016.09.138
Prurigo chronique de l’enfant : formes cliniques et profils de sensibilisation aux allergenes de l’environnement. Étude prospective ☆
Claire Maridet (2016)
10.7241/ourd.20122.22
SPOROTRICHOID ATOPIC PRURIGO. A COMMON CONDITION WITH AN UNUSUAL CLINICAL PRESENTATION SPOROTRICHOID ATOPIC PRURIGO. CZĘSTE SCHORZENIE O NIEZWYKŁEJ PREZENTACJI KLINICZNEJ
Beatriz Di (2012)
Topical immunomodulators in dermatology.
Sujay Khandpur (2004)
10.1159/000056351
Tacalcitol, an Active Vitamin D3, Induces Nerve Growth Factor Production in Human Epidermal Keratinocytes
M Fukuoka (2001)
10.1111/jdv.15040
Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo
J Pölking (2018)
Semantic Scholar Logo Some data provided by SemanticScholar